Rational design of complementary peptides to the βAmyloid 29-42 fusion peptide: An application of PepDesign

Biochimica et Biophysica Acta - Biomembranes

Volumn 1758, Issue 3, 2006, Pages 320-327

  Decaffmeyer, Marc ^a   Lins, Laurence ^a   Charloteaux, Benoit ^a   VanEyck, Marie Hélène ^b   Thomas, Annick ^a   Brasseur, Robert ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Parc Crealys   (Belgium)

Author keywords

Alzheimer; Amyloid; Angular dynamic; ApoE; Complementary peptide; Computer aided design; In silico design; Peptide interaction; Tilted peptide

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[29-42]; APOLIPOPROTEIN E; APOLIPOPROTEIN E[270-287]; APOLIPOPROTEIN E[270-287] AMYLOID BETA PROTEIN[29-42] FUSION PROTEIN; HYBRID PROTEIN; LIPID; LIPOSOME; MUTANT PROTEIN; UNCLASSIFIED DRUG; APOLIPOPROTEIN E (270 287); APOLIPOPROTEIN E (270-287); BETA AMYLOID PEPTIDE (29 42); BETA-AMYLOID PEPTIDE (29-42); PEPTIDE FRAGMENT;

AMINO ACID SUBSTITUTION; CALCULATION; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; COMPUTER MODEL; CONFORMATIONAL TRANSITION; MOLECULAR INTERACTION; MONTE CARLO METHOD; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROCESS DESIGN; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; REVIEW; STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS; AMINO ACID SEQUENCE; ARTICLE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; GENETICS; HUMAN; METHODOLOGY; MOLECULAR GENETICS; MUTATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; COMPUTATIONAL BIOLOGY; DRUG DESIGN; HUMANS; LIPOSOMES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDE FRAGMENTS;

EID: 33646805314     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2005.10.001     Document Type: Review

References (34)

1. Kasher R., Balass M., Scherf T., Fridkin M., Fuchs S., and Katchalski-Katzir E. Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity. ChemBiology 8 (2001) 147-155
2. Katchalski-Katzir E., Kasher R., Balass M., Scherf T., Harel M., Fridkin M., Sussman J.L., and Fuchs S. Design and synthesis of peptides that bind α-bungarotoxin with high affinity and mimic the three-dimensional structure of the binding-site of acetylcholine receptor. Biophys. Chem. 100 1-3 (2003) 293-305 (15 January)
3. Yang Z., Feng J., Li Y., Hu M., Song L., Yu M., Qin W., and Shen B. Structure-based design and characterization of a Novel IL-6 antagonist peptide. Mol. Immunol. 42 9 (2005) 1015-1021
4. Shoji M. Cerebrospinal fluid Abeta 40 and Abeta 42: natural course and clinical usefulness. Front. Biosci. 7 (2002) 997-1006
5. Galasko D. Cerebrospinal fluid levels of A beta 42 and tau: potential markers of Alzheimer's disease. J. Neural Transm., Suppl. 53 (1998) 209-221
6. Gooch M.D., and Stennett D.J. Molecular basis of Alzheimer's disease. Am. J. Health-Syst. Pharm. 53 (1996) 1545-1557
7. Brasseur R. Tilted peptides: a motif for membrane destabilisation (hypothesis) Mol. Mem. Biol. 17 (2000) 31-40
8. Martin I., Defrise-Quertain F., Mandieau V., Nielsen N., Saermark T., Burny A., Brasseur R., Ruysschaert J.M., and Vandenbranden M. Fusogenic activity of SIV (simian immunodeficiency virus) peptides located in the GP32 NH2 terminal domain. Biochem. Biophys. Res. Commun. 175 (1991) 872-879
9. Voneche V., Portetelle D., Kettmann R., Willems L., Limbach K., Paoletti E., Ruysschaert J.M., Burny A., and Brasseur R. Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. Proc. Natl. Acad. Sci. U.S.A 89 (1992) 3810-3814
10. Pillot T., Goethals M., Vanloo B., Talussot C., Brasseur R., Vandekerckhove J., Rosseneu M., and Lins L. Fusogenic properties of the C-terminal domain of the Alzheimer β-Amyloid peptide. J. Biol. Chem. 271 (1996) 28757-28765
11. Pillot T., Goethals M., Najib J., Labeur C., Lins L., Chambaz J., Brasseur R., Vandekerckhove J., and Rosseneu M. β-Amyloid peptide interacts specifically with the carboxy-terminal domain of human Apolipoprotein E: relevance to Alzheimer disease. J. Neurochem. 72 (1999) 230-237
12. Pillot T., Goethals M., Vanloo B., Lins L., Brasseur R., Vandekerckhove J., and Rosseneu M. Specific modulation of the fusogenic properties of the Alzheimer beta-amyloid peptide by the apolipoprotein E isoforms. Eur. J. Biochem. 243 (1997) 650-659
13. Roses A.D. The Alzheimer disease. Curr. Opin. Neurobiol. 6 (1996) 644-650
14. Lins L., Thomas-Soumarmon A., Pillot T., Vandekerchkhove J., Rosseneu M., and Brasseur R. Molecular determinant of the interaction of the interaction between the C-terminal doamin of the Alzheimer's β-amyloid peptide and apolipoprotein E α-helices. J. Neurochem. 73 (1999) 758-769
15. Creighton T.E. Proteins: Structures and Molecular Properties, Library of Congress Cataloging-In Publication Data. 2nd ed. (1997)
16. Brasseur R., Goormaghtigh E., and Ruysschaert J.M. Theoretical conformational analysis of phospholipid bilayers. Biochem. Biophys. Res. Commun. 103 (1981) 301-310
17. Thomas A., Bouffioux O., Geeurickx D., and Brasseur R. Pex, analytical tools for PDB files: I. GF-Pex: basic file to describe a protein. Proteins 43 (2001) 28-36
18. Thomas A., Meurice R., Charloteaux B., and Brasseur R. Aromatic side-chain interaction in proteins. Main structural feature. Proteins, Struct., Funct. Genet. 48-4 (2002) 628-644
19. Lins L., Thomas A., and Brasseur R. Analysis of accessible surface of residues in proteins. Protein Sci. 12 (2003) 1406-1417
20. Brasseur R. Simulating the folding of small proteins by use of the local minimum energy and the free solvation energy yields native-like structures. J. Mol. Graph. 13 (1995) 312-322
21. Levitt M. Protein folding by restrained energy minimization and molecular dynamics. J. Mol. Biol. 170 (1983) 723-764
22. Thomas A., Milon A., and Brasseur R. Partial atomic charges of amino acids in proteins. Proteins, Struct. Funct. Bioinform. 56 1 (2004) 102-109
23. Melot F., and Feytmans E.J. Novel knowledge-base mean force potential at atomic level. Mol. Biol. 267/1 (1997) 207-222
24. Word J.M., Lovell S.C., LaBean T.H., Taylor H.C., Zalis M.E., Presley B.K., Richardson J.S., and Richardson D.C. Visualizing and quantifying molecular goodness-of-fit: small-probe contact dots with explicit hydrogen atoms. J. Mol. Biol. 285 4 (1999) 1711-1733
25. Barlett G.R. Colorimetric assay methods for free and phosphorylated glyceric acids. J. Biol. Chem. 65 (1959) 2146-2156
26. Hoekstra D., and Klappe K. Use of a fluorescence assay to monitor the kinetics of fusion between erythrocyte ghosts, as induced by Sendai virus. Biosci. Rep. 6 (1986) 953-960
27. Ellens H., Bentz J., and Szoka F.C. H+- and Ca2+-induced fusion and destabilization of liposomes. Biochemistry 24 (1985) 3099-3106
28. Brasseur R., Lins L., Vanloo B., Ruysschaert J.M., and Rosseneu M. Molecular modeling of the amphipathic helices of the plasma apolipoproteins. Proteins 13 3 (1992) 246-257
29. Mingeot-Leclercq M.-P., Lins L., Bensliman M., Van Bambeke F., Van Der Smissen P., Peuvot J., Schanck A., and Brasseur R. Membrane destabilization induced by β-amyloid peptide 29-42: importance of the amino-terminus. Chem. Phys. Lipids 120 (2002) 57-74
30. Campbell W., Kleiman L., Baranyi L., Li Z., Khorchid A., Fujita E., Okada N., and Okada H. A novel genetic algorithm for designing mimetic peptides that interfere with the function of a target molecule. Microbiol. Immunol. 46 3 (2002) 211-215
31. Shimomura Y., Kawamura T., Komura H., Campbell W., Okada N., and Okada H. Modulation of procarboxypeptidase R (ProCPR) activation by complementary peptides to thrombomodulin. Microbiol. Immunol. 47 3 (2003) 241-245
32. Basyn F., Spies B., Bouffioux O., Thomas A., and Brasseur R. Insertion of X-ray structures of proteins in membranes. J. Mol. Graph. Model. 22 (2003) 11-21
33. Lejeune D., Delsaux N., Charloteaux B., and Thomas A. Protein-nucleic acids recognition: Statistical analysis of atomic interactions and influence of DNA structure. Proteins : Structure, Function, and Bioinformatics 61 2 (2005) 258-271
34. L. Lins, B. Charloteaux, C. Heinen, A. Thomas, R. Brasseur, De novo design of peptides with specific lipid-binding properties, Biophys. J. (in press).